https://www.prnewswire.com/news-releases/citius-pharmaceuticals-and-citius-oncology-announce-unique-permanent-j-code-issued-for-lymphir-by-centers-for-medicare-and-medicaid-services-302369992.html
Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by...
/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) and its oncology-focused subsidiary, Citius Oncology, Inc....